CJC-1295 & Ipamorelin Nasal 500mcg

Description

CJC-1295 & Ipamorelin Nasal Spray (500mcg) delivers two potent growth hormone secretagogues via a convenient transnasal route, allowing for non-invasive administration in preclinical research. CJC-1295, a GHRH analog, and Ipamorelin, a GHRP that selectively stimulates ghrelin receptors, are commonly studied together for their complementary roles in promoting growth hormone (GH) release.

This nasal formulation enables easy and targeted delivery without the need for injection, making it especially useful for studies involving consistent, repeated dosing or hormone rhythm regulation. Together, these peptides may enhance GH pulsatility, support metabolic balance, and aid in tissue regeneration.

How CJC-1295 & Ipamorelin Nasal Works:

• CJC-1295: Prolongs and amplifies GH pulses through GHRH receptor stimulation

• Ipamorelin: Mimics ghrelin to trigger GH release without affecting cortisol or prolactin

• Nasal delivery allows for systemic absorption via the mucosal membrane

• Designed for easy use in repetitive, time-sensitive preclinical protocols

Potential Benefits (Based on Preclinical Research):

• Enhanced natural GH secretion through dual-pathway stimulation

• May support lean muscle growth, recovery, and fat metabolism

• Non-invasive delivery suited for research involving neuroendocrine signaling

• No significant impact on stress hormones or hunger levels

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.